Brief: Evolus Q1 Product Revenue USD 68.074 Million
07/05/2025 21:05
May 07 (Reuters) - Evolus Q1 adjusted gross margin 69.2%. Q1 gross margin 68.1% Q1 net income USD -18.892 million Q1 gross profit USD 46.655 million outlook FY sales USD 345-355 million outlook FY sales growth 30%
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe